PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Toxicity|Neurotoxicity|Drug Toxicity|Adverse Drug Event
Interventions: DRUG: ERIBULIN MESYLATE
Sponsor: Oncologia Medica dell'Ospedale Fatebenefratelli
Collaborators: Mario Negri Institute for Pharmacological Research